Induced expression of lectin-like oxidized ldl receptor-1 in vascular smooth muscle cells following Chlamydia pneumoniae infection and its down-regulation by fluvastatin
- PMID: 20587387
- DOI: 10.1556/AMicr.57.2010.2.7
Induced expression of lectin-like oxidized ldl receptor-1 in vascular smooth muscle cells following Chlamydia pneumoniae infection and its down-regulation by fluvastatin
Abstract
Microorganisms such as Chlamydia pneumoniae have been shown to infect vascular cells and are believed to contribute to vascular inflammation and atherosclerotic plaque development. Plasma levels of oxidized low density lipoprotein (oxLDL) have received considerable attention as potential predictors of prognosis in atherosclerotic diseases. Lectin-like oxidized LDL receptor-1 (LOX-1) is one of the major receptors for oxidized LDL. It was investigated whether C. pneumoniae infection can stimulate expression of LOX-1 in vascular smooth muscle cells. Expression of LOX-1 in VSMC was measured by RT-PCR and immunoblotting following C. pneumoniae infection. To examine the pharmacological effect of a HMG-CoA reductase inhibitor on LOX-1 expression, cells were co-incubated with fluvastatin immediately after infection. A dose and time dependent expression of LOX-1mRNA and protein was found in C. pneumoniae infected SMC. After heat and UV light treatment of the chlamydial inoculum the level of LOX-1 was reduced to that of mock-infected cultures. Furthermore, treatment of infected cells with fluvastatin decreased LOX-1 expression to baseline levels. The up-regulation of LOX-1 induced by C. pneumoniae could lead to continued lipid accumulation in atherosclerotic lesions. Together with the widespread expression of LOX-1, this might contribute to the epidemiologic link between C. pneumoniae infection and atherosclerosis. The effect of lowering the LOX-1 expression by fluvastatin may provide a pharmacological option of limiting oxLDL uptake via its scavenger receptor.
Similar articles
-
Fluvastatin prevents renal injury and expression of lactin-like oxidized low-density lipoprotein receptor-1 in rabbits with hypercholesterolemia.Chin Med J (Engl). 2005 Apr 20;118(8):621-6. Chin Med J (Engl). 2005. PMID: 15899115
-
Chlamydia pneumoniae infection enhances lectin-like oxidized low-density lipoprotein receptor (LOX-1) expression on human endothelial cells.FEMS Microbiol Lett. 2006 Jul;260(1):17-22. doi: 10.1111/j.1574-6968.2006.00286.x. FEMS Microbiol Lett. 2006. PMID: 16790013
-
Oxidized LDL promotes the mitogenic actions of Chlamydia pneumoniae in vascular smooth muscle cells.Cardiovasc Res. 2011 Dec 1;92(3):476-83. doi: 10.1093/cvr/cvr251. Cardiovasc Res. 2011. PMID: 22072707
-
LOX-1, the receptor for oxidized low-density lipoprotein identified from endothelial cells: implications in endothelial dysfunction and atherosclerosis.Pharmacol Ther. 2002 Jul;95(1):89-100. doi: 10.1016/s0163-7258(02)00236-x. Pharmacol Ther. 2002. PMID: 12163130 Review.
-
Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in atherogenesis.Trends Cardiovasc Med. 2001 Jan;11(1):22-5. doi: 10.1016/s1050-1738(01)00079-2. Trends Cardiovasc Med. 2001. PMID: 11413048 Review.
Cited by
-
Chlamydia pneumoniae infection in atherosclerotic lesion development through oxidative stress: a brief overview.Int J Mol Sci. 2013 Jul 19;14(7):15105-20. doi: 10.3390/ijms140715105. Int J Mol Sci. 2013. PMID: 23877837 Free PMC article. Review.
-
Infectious Agents in Atherosclerotic Cardiovascular Diseases through Oxidative Stress.Int J Mol Sci. 2017 Nov 18;18(11):2459. doi: 10.3390/ijms18112459. Int J Mol Sci. 2017. PMID: 29156574 Free PMC article. Review.
-
Chlamydophila pneumoniae infection and cardiovascular disease.N Am J Med Sci. 2013 Mar;5(3):169-81. doi: 10.4103/1947-2714.109178. N Am J Med Sci. 2013. PMID: 23626952 Free PMC article.
-
Chlamydia pneumoniae and oxidative stress in cardiovascular disease: state of the art and prevention strategies.Int J Mol Sci. 2014 Dec 30;16(1):724-35. doi: 10.3390/ijms16010724. Int J Mol Sci. 2014. PMID: 25561227 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Medical